Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Trading Update

12 Apr 2012 07:00

RNS Number : 1659B
Byotrol PLC
12 April 2012
 



 

 12 April 2012

Byotrol plc

Trading Update

 

 

Byotrol plc ('Byotrol' or the "Company"), the developer of anti microbial hygiene technologies, is pleased to provide a trading update for the year to 31 March 2012, in advance of its annual results which are scheduled to be announced in June.

 

Trading Performance

 

Byotrol reports that it has seen growth in revenue in the second half of the year and results are expected to be in line with market expectations. Revenue for the year is anticipated to be approximately £1.96m (2011: £1.93m) and the cash balance at 31 March 2012 was £1.6m which is higher than previously anticipated. The Company has also successfully completed the technical milestones required by its Fortune 150 partner.

 

Operational Highlights

 

The year to 31 March 2012 saw the market launch of Rentokil Initial plc's UltraProtect™ range of hand and surface sanitising products, powered by Byotrol, under the contract announced in July 2011. Plans are underway to introduce UltraProtect™ across Europe in the remainder of 2012. It is expected that the new revolutionary sanitiser will soon be available in more than ten countries, and it has already launched in the UK, France and Germany. The Company expects further revenue growth in the coming year from this agreement.

 

The Company also reports that its technology has been adopted across the entire fleet of cruise line operator Holland America as the anti-microbial control choice for high contact touch areas.

 

Byotrol has continued to receive industry accolades for its revolutionary product as evidenced by its recent receipt of the prestigious 'Chemicals North-West 2012 Innovation Award' and shortlistings for the upcoming Chemicals UK equivalent and British Sandwich Association technical excellence award.

 

Byotrol Consumer Products Limited continues to work under a Joint Development Agreement with its Fortune 150 partner company having successfully completed the technical milestones required. The two companies are currently completing consumer research and commercial analysis with the aim of a decision on a full commercial agreement in the second half of 2012.

 

In addition, the Company is now benefitting from its technology being used in products sold by PZ Cussons, the Mayborn Group (owners of the Tommee Tippee brand), Boots and Tesco, among others. In particular, and via its relationship with Robert McBride Ltd, the Company has recently increased its presence in Tesco stores from one to three different trigger spray anti bacterial products.

 

 

Gary Millar, CEO of Byotrol, commenting said:

 

"Byotrol's new commercial strategy is already generating more repeatable, sustainable revenues with key strategic partners. The trading performance and tight cost control shows that the Company is moving in the right direction, and we look forward to further progress in the coming financial year."

 

 

Enquiries:

 

Byotrol plc

Gary Millar - Chief Executive

Richard Bell - Finance Director

 

finnCap

Geoff Nash/Christopher Raggett - Corporate Finance

Simon Starr - Corporate Broking

 

Winningtons

Tom Cooper/Paul Vann

01925 742 000

 

 

 

020 7220 0500

 

 

020 3176 4722

0797 122 1972

tom.cooper@winningtons.co.uk

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a standalone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQFLFFLZFLBBZ
Date   Source Headline
6th Apr 202010:56 amRNSHolding(s) in Company
2nd Apr 202011:05 amRNSSecond Price Monitoring Extn
2nd Apr 202011:00 amRNSPrice Monitoring Extension
24th Mar 20209:05 amRNSSecond Price Monitoring Extn
24th Mar 20209:00 amRNSPrice Monitoring Extension
23rd Mar 20207:01 amRNSTrading Update
23rd Mar 20207:00 amRNSLicence and Product Supply Agreement with Tristel
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20202:05 pmRNSSecond Price Monitoring Extn
13th Mar 20202:00 pmRNSPrice Monitoring Extension
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20204:15 pmRNSHolding(s) in Company
30th Jan 20205:00 pmRNSDirector/PDMR Shareholding
30th Jan 20208:00 amRNSAcceleration of earn-out relating to Medimark
19th Dec 20197:00 amRNSInterim Results
14th Nov 201912:30 pmRNSResult of AGM
13th Nov 20197:00 amRNSHolding(s) in Company
8th Nov 20192:54 pmRNSHolding(s) in Company
11th Oct 20193:00 pmRNSPosting of Accounts, Notice of AGM and Restoration
11th Oct 20193:00 pmRNSRestoration - Byotrol Plc
1st Oct 20193:50 pmRNSHolding(s) in Company
1st Oct 20197:30 amRNSSuspension - BYOTROL PLC
30th Sep 201912:01 pmRNSPublication of accounts and temporary suspension
30th Sep 201912:00 pmRNSUnaudited Preliminary Results to 31 March 2019
25th Sep 20197:00 amRNSNotice of Results
3rd Sep 20199:08 amRNSNotice of Results
28th May 20197:00 amRNSAppointment of CFO & Award of Options
9th May 20197:00 amRNSTrading Update
15th Apr 201911:58 amRNSHolding(s) in Company
28th Feb 20197:00 amRNSEPA Approval and Target Roll-Out
31st Jan 20199:14 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSAppointment of New Director & Award of Options
31st Dec 20187:00 amRNSGrant of Options
21st Dec 20181:41 pmRNSHolding(s) in Company
21st Dec 20181:41 pmRNSHolding(s) in Company
20th Dec 201812:07 pmRNSDirector Dealings
18th Dec 20187:00 amRNSInterim Results
14th Nov 201810:35 amRNSHolding(s) in Company
13th Nov 20184:00 pmRNSHolding(s) in Company
13th Nov 201811:20 amRNSDirector/PDMR Shareholding
12th Nov 20185:05 pmRNSHolding(s) in Company
21st Sep 20184:00 pmRNSResult of AGM
4th Sep 201811:15 amRNSPosting of Annual Report and Notice of AGM
3rd Sep 20184:48 pmRNSHolding(s) in Company
3rd Sep 20184:12 pmRNSHolding(s) in Company
24th Aug 201812:01 pmRNSDirector Dealing
24th Aug 20187:00 amRNSDirector Dealing
23rd Aug 201811:31 amRNSAcquisition of Medimark Scientific Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.